Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NMO Spectrum Disorder (NMOSD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07420296
What this trial is testing

Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorders (NMOSD)
Tianjin Medical University General Hospital 198
Post-approval studies (Phase 4)UnknownNCT06212245
What this trial is testing

A Clinical Research Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis Optica Spectrum Disorders
Hansoh BioMedical R&D Company 33
Large-scale testing (Phase 3)Study completedNCT04201262
What this trial is testing

An Efficacy and Safety Study of Ravulizumab in Adult Participants With NMOSD

Who this might be right for
Neuromyelitis OpticaNeuromyelitis Optica Spectrum Disorder
Alexion Pharmaceuticals, Inc. 58
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07809724
What this trial is testing

Efficacy and Safety of Low-Dose IL-2 in Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder (NMOSD)
Peking University People's Hospital 60
Not applicableStudy completedNCT03452176
What this trial is testing

Scrambler Trial for Pain in NMOSD

Who this might be right for
Neuromyelitis Optica
Johns Hopkins University 22
Post-approval studies (Phase 4)Study completedNCT05896605
What this trial is testing

Monitoring of Azathioprine Metabolite Concentrations and Cytokine Levels in Neuromyelitis Optica Spectrum Disorder

Who this might be right for
NMO Spectrum DisorderAzathioprine Adverse Reaction
First Affiliated Hospital of Guangxi Medical University 63
Not applicableEnrolling By InvitationNCT04886492
What this trial is testing

CorEvitas SPHERES (Synergy of Prospective Health & Experimental Research for Emerging Solutions) Registry for Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
CorEvitas 800
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07804004
What this trial is testing

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Refractory Neurologic Autoimmune Disease

Who this might be right for
Progressive Multiple Sclerosis (PMS)Neuromyelitis OpticaMyelin Oligodendrocyte Glycoprotein Antibody-associated Disease+2 more
CRISPR Therapeutics 220
Testing effectiveness (Phase 2)Looking for participantsNCT06453694
What this trial is testing

Efgartigimod for the Treatment of Acute Optic Neuritis

Who this might be right for
Optic Neuritis
Anastasia Vishnevetsky, MD, MPH 20
Not applicableLooking for participantsNCT05909761
What this trial is testing

Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregnancy

Who this might be right for
Neuromyelitis Optica Spectrum DisorderPregnancy Related
Amgen 60
Not applicableLooking for participantsNCT07653984
What this trial is testing

Cohort Study on Neuroimmune Diseases in the Reproductive Age

Who this might be right for
Neuromyelitis Optica Spectrum Disorders (NMOSD)Multiple SclerosisAutoimmune Encephalitis+3 more
Third Affiliated Hospital, Sun Yat-Sen University 100
Not applicableLooking for participantsNCT06829524
What this trial is testing

HANDLE-a Real World Study on Satralizumab in NMOSD

Who this might be right for
Neuromyelitis Optica Spectrum Disorders (NMOSD)
Huashan Hospital 100
Post-approval studies (Phase 4)Active Not RecruitingNCT06180278
What this trial is testing

Long-term, Open-label, Safety Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Amgen 32
Not applicableEnrolling By InvitationNCT06374264
What this trial is testing

Acceptability and Safety of MR-C-014 in Persons With Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
MedRhythms, Inc. 30
Not applicableNot Yet RecruitingNCT07266051
What this trial is testing

Prospective Cohort Study of Neuromyelitis Optica Spectrum Disorders (NMOSD)

Who this might be right for
NMOSD
Xiamen Hospital of Traditional Chinese Medicine 4,000
Not applicableNot Yet RecruitingNCT06903130
What this trial is testing

Clinical Study to Evaluate the Effects of the Complement C5 Inhibitor Ravulizumab on Serum Neurofilament Light Chain (sNfL) and Glial Fibrillary Acidic Protein (sGFAP) Levels in Patients With Aquaporin-4-Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
NMOSD
National and Kapodistrian University of Athens 40
Not applicableNot Yet RecruitingNCT07182409
What this trial is testing

Efficacy and Safety of Monoclonal Antibody in Acute Phase of Neuromyelitis Optica Spectrum Disorder

Who this might be right for
NMOSD
First Affiliated Hospital of Chongqing Medical University 40
Not applicableLooking for participantsNCT05566769
What this trial is testing

Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD

Who this might be right for
Neuromyelitis Optica
Ad scientiam 103
Testing effectiveness (Phase 2)Looking for participantsNCT06697535
What this trial is testing

Evaluate the Efficacy and Safety of JYP0061 in Patients With Acute Neuromyelitis Spectrum Disease (NMOSD)

Who this might be right for
Neuromyelitis Optica Spectrum Disorders
Guangzhou JOYO Pharma Co., Ltd 35
Large-scale testing (Phase 3)Study completedNCT02028884
What this trial is testing

Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD)

Who this might be right for
Neuromyelitis Optica (NMO)NMO Spectrum Disorder (NMOSD)
Hoffmann-La Roche 85
Next Page